← Leaderboards
Conor Caffrey
University Of California, San Francisco
$4,887,893
Attributed
$9,552,070
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,552,070 · 11
By mechanism
U01$4,559,463 · 1
R21$3,645,945 · 9
R01$1,346,662 · 1
Top collaborators
- Carlo Ballatore6 shared
- Anjan Debnath4 shared
- Rahul Singh4 shared
- Michelle Arkin3 shared
- Anthony John O'Donoghue3 shared
- Kurt R. Brunden2 shared
- Larissa M. Podust2 shared
- Arek Goetz1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Charles Scott Craik$31,131,909
- Gregory Michael Ku$5,449,009
- Andrew J Ambrose$231,766
- Larissa M. Podust$3,291,001
- Daniel Schwarz$74,578
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsParasitesDesignDrug DiscoveryNovel TherapeuticsProgramsStructureIn VitroSmall MoleculeBaseDrug TargetingSeriesParasitic DiseasesInfectionFutureWorld Health OrganizationSchistosome ParasiteResponseSchistosomiasisDrug DevelopmentDrug KineticsDrug ResistancePraziquantelCells
Grant awards (21)
Development of a MT-stabilizing agent for the treatment of tauopathies$2,250,355
U01 · FY2025 · AG · contact PI
New tools to facilitate drug discovery for pathogen proteasomes$438,500
R21 · FY2025 · AI
Development of a MT-stabilizing agent for the treatment of tauopathies$2,309,108
U01 · FY2024 · AG · contact PI
The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis$197,500
R21 · FY2023 · AI · contact PI
The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis$237,000
R21 · FY2022 · AI · contact PI
Development of thiophen-2-yl-phenylpyrimidines for treatment of schistosomiasis$197,500
R21 · FY2022 · AI · contact PI
Development of thiophen-2-yl-phenylpyrimidines for treatment of schistosomiasis$237,000
R21 · FY2021 · AI · contact PI
Brain Penetrant Microtubule-Stabilizers to Treat CNS-invasive Parasitic Diseases$252,094
R21 · FY2020 · AI
Reasoning with chemically induced dynamic phenotypes in whole-organism assays$233,375
R21 · FY2020 · AI
Translational development of cysteine protease inhibitors to treat hookworm disease$196,875
R21 · FY2020 · AI · contact PI
Translational development of cysteine protease inhibitors to treat hookworm disease$236,250
R21 · FY2019 · AI · contact PI
Reasoning with chemically induced dynamic phenotypes in whole-organism assays$204,803
R21 · FY2019 · AI
Brain Penetrant Microtubule-Stabilizers to treat CNS-invasive parasitic diseases$193,750
R21 · FY2019 · AI · contact PI
Brain Penetrant Microtubule-Stabilizers to Treat CNS-invasive Parasitic Diseases$189,122
R21 · FY2019 · AI
Brain Penetrant Microtubule-Stabilizers to treat CNS-invasive parasitic diseases$232,500
R21 · FY2018 · AI · contact PI
Defining the death transcriptome of Schistosoma mansoni to construct a molecular drug screen$182,750
R21 · FY2018 · AI · contact PI
Defining the death transcriptome of Schistosoma mansoni to construct a molecular drug screen$232,500
R21 · FY2017 · AI · contact PI
Exploring statins as a small molecule therapy for treatment of schistosomiasis$184,426
R21 · FY2013 · AI · contact PI
An automated high throughput phenotypic screen for schistosomiasis drug discovery$428,854
R01 · FY2012 · AI · contact PI
An automated high throughput phenotypic screen for schistosomiasis drug discovery$423,139
R01 · FY2011 · AI · contact PI
An automated high throughput phenotypic screen for schistosomiasis drug discovery$494,669
R01 · FY2010 · AI · contact PI